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Notch-Delta signaling of hematopoietic precursors sets in motion a train of events that activates
expression of T lineage genes. Even so, throughmany cell generations the pro-T cells remain uncom-
mitted to the T cell fate, preserving alternative potentials as divergent as monocyte or dendritic cell
fates. This plasticity can be explained by the tenacious expression of stem- and progenitor-associ-
ated regulatory genes in the cells, and by the combinatorial coding of T cell identity by factors that are
not intrinsically T lineage specific in their spectra of activity. T lineage developmental success
depends on precise temporal and quantitative regulation of these factors and on the continuingmod-
ulating influence of Notch-Delta signals that buffer the cells against mechanisms promoting non-T
outcomes. An additional mechanism, still not fully defined, is required just prior to T cell receptor-
mediated selection to end plasticity and make T lineage commitment irreversible.Step-wise, Lineage-Specific Exclusions
as the Basis for T Lineage Commitment
Stem cells do not directly choose a T lineage fate; rather, T
cell precursors gradually relinquish their stem-like pluripo-
tentiality. Individual alternatives to the T lineage fate choice
are shed at different stages in the progression of hemato-
poietic precursors toward commitment. Thus, the mecha-
nisms through which T cell precursors adopt their fate are
a series of specific lineage exclusions, each mediated by
effects on a distinct set of regulators.Meanwhile, T lineage
differentiation, in terms of distinctive surface phenotypes
and functionally important gene expression, begins to be
activated long before commitment is complete. The early
stages of T lineage choice must therefore be understood
as an interweaving of gains and losses of function.
Figure 1 provides the general progression of stages fol-
lowed by murine multipotent precursors through T lineage
commitment to later, T cell receptor (TCR)-dependent
phases of T cell development. Distinct prethymic precursors
that can enter this pathway are discussed in an accompany-
ing review (Bhandoola et al., 2007). The most primitive intra-
thymicprecursorswith thegreatest proliferativepotential are
c-Kit+DN1cells (‘‘doublenegative:’’CD4CD8TCRCD3;
c-Kit+ DN1, also c-Kit+CD44+CD25) (Ceredig and Rolink,
2002; Porritt et al., 2004; Allman et al., 2003), which are still
equivocal in their T lineage gene-expression status. Multi-
ple T lineage genes are clearly upregulated by the next
stage, the DN2 stage (c-Kit+CD44+CD25+), although the
Rag1 and Rag2 recombinase complex is still expressed
only at low amounts and little TCR rearrangement is
seen. The cells proliferate extensively in the c-Kit+ DN1
and DN2 stages, but this proliferation stalls at the DN3
stage (c-KitCD44CD25+), and this is where the major
phase of TCR rearrangement begins. Although DN3 cells
express some distinctive genes that mark them as imma-690 Immunity 26, June 2007 ª2007 Elsevier Inc.ture, they unequivocally express all genes needed for T
cell signaling. There is a major developmental checkpoint
at the DN3 stage, and these cells may never proliferate
again unless they successfully complete TCR rearrange-
ments so as to express a full gd TCRcomplex (for gd selec-
tion) or a full TCRb chain (for b selection). These selection
events are the portals to later T cell development and im-
munological function. The events described in this review,
however, occurmainly in thepro-Tcell stages leadingup to
the first TCR-based selection checkpoint.
The general timing of steps toward T lineage commit-
ment has emerged from studies over the last decade
that have used bulk-purified populations, then single-cell
assays, in a variety of readout systems, from adoptive
transfer into irradiated hosts to cytokine-supplemented
fetal thymus organ cultures to special stromal cultures
that allow multilineage development (Wu et al., 1996;
Carlyle et al., 1997; Katsura and Kawamoto, 2001; Dallas
et al., 2005; Benz and Bleul, 2005). The key to detecting all
non-T alternatives is to remove the cells from the thymus
and to supply the cells with cytokines that support the
particular alternative fate or fates being tested. Bound-
aries between developmental fates are crisply drawn by
switches in growth-factor requirements, and T cell-per-
missive conditions as a rule do not keep alive cells that de-
viate to other pathways, unless the cells are engineered to
express Bcl2 constitutively (Taghon et al., 2007; Franco
et al., 2006). None of these assays is perfect. For reasons
discussed later, all are best at detecting pluripotency in
cells that can proliferate and disperse their individual
progeny to different microenvironments before they un-
dergo lineage choice. Nevertheless, consistent results
show that erythromegakaryocytic potential is lost from
multilineage lymphoid precursors that still retain access
to various myeloid fates (Katsura and Kawamoto, 2001;
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ReviewsFigure 1. Outline of T Cell Developmental Stages
Stages of T cell development are shown as described in the text. Broken purple curve denotes stage of entry into the thymus. Shaded green area at
right denotes T cell receptor-dependent stages of thymocyte development. Potential developmental pathways for precursors before entry into the
thymus are not necessarily comprehensive but illustrate common patterns seen. Within thymus, solid lines indicate pathways that are highly acces-
sible. Broken lines indicate pathways that are accessible only in the absence of Notch-Delta signaling. Intrathymic c-Kit+ DN1, DN2, and DN3 stages
before b selection are all Notch dependent for survival and are referred to as ‘‘pro-T cell’’ stages. Abbreviations: DN4, CD4CD8 intracellular TCRb+;
ISP, ‘‘immature single positive;’’ both developmental intermediates between b selection and the DP stage. DP, CD4+CD8+TCRablow. Further
development, to CD8 (CD8+CD4TCRab+), CD4 (CD4+CD8TCRab+), T-reg (regulatory T), or NKT (natural killer T) T cell lineages, depends on
abTCR-dependent positive selection.Adolfsson et al., 2005; Yoshida et al., 2006); that B cell
potential is lost before or immediately after entry into the
thymus (Sambandam et al., 2005; Tan et al., 2005; Benz
and Bleul, 2005; Bhandoola et al., 2007, in this issue);
and that the last choices are between T, natural killer
(NK), and myeloid or dendritic cell (DC) fates (Lucas
et al., 1998; Ikawa et al., 1999; Lee et al., 2001; Shen
et al., 2003; Schmitt et al., 2004; Balciunaite et al., 2005).
The NK and DC pathways remain open to intrathymic
cells at high frequency not only in DN1 but also in DN2
stage cells, in both adult and fetal systems. Only at the
DN3 stage do the cells stop exhibiting these alternative
potentials. The DN2 identification of the incompletely
committed cells is important because it sets a minimum
time window throughout which the NK, DC, and mono-
cytic alternatives must persist. The DN2 stage in the post-
natal thymus is apparently reached only after >1 week of
intrathymic proliferation (Petrie, 2003) and a resulting
100- to 1000-fold population expansion in the thymic
microenvironment (Kawamoto et al., 2003). Thus, the
NK,DC, andmacrophageoptionscanbe actively preserved
by the T cell precursors through as many as ten cell divi-
sions after the cells enter the thymus.
Commitment at the DN3 stage is not simply due to
repression of growth factor receptors needed by non-T
lineage cells. For example, even when cells are genetically
manipulated to express amyeloid-triggering growth factorreceptor constitutively, the same discontinuity is seen
between the DN2 to DN3 stages (King et al., 2002;
Iwasaki-Arai et al., 2003). Activation of these ectopic
receptors greatly potentiates differentiation of DN1 and
DN2 cells to myeloid fates, and in these experiments the
cells even show a neutrophil potential that is not seen in
unmanipulated thymocytes. However, the ability of the
cells to make this ectopic cytokine receptor-driven
response is again lost between the DN2 and DN3 stages.
Thus, there is an intrinsic change in regulatory state at
the DN3 stage that terminates access to alternative devel-
opmental programs regardless of signaling conditions.
Notch-Delta Signaling: A Multilevel Regulator
of T Cell Development
For successful negotiation of the whole T lineage commit-
ment process, multiple transcriptional inputs are neces-
sary, as shownby germline and conditional gene knockout
experiments. There are essential roles for GATA-3, TCF
family factors, the ‘‘E proteins’’ E2A or HEB, Ikaros family
factors, Myb, Gfi-1, Runx family factors, the Ets family fac-
tor PU.1, and activation of the CSL transcription factor
by signaling from Notch-Delta interaction (reviewed by
Rothenberg, 2007; Blom and Spits, 2006; Rothenberg
and Taghon, 2005; Staal et al., 2001). Of these, Notch-
Delta signaling has a very special role: it is the only one
of these regulators that can specifically drive uncommittedImmunity 26, June 2007 ª2007 Elsevier Inc. 691
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ReviewsFigure 2. Possible Modes of Action of
Notch-Delta Signaling in the T Lineage-
Specification Network
Four different modes of action are depicted
through which Notch-Delta signaling partici-
pates in T lineage differentiation. Most are
based on the known transcriptional mecha-
nism for Notch activity (left), in which signaling
causes intracellular Notch (Notch IC) to be
cleaved and transported to the nucleus where
it converts the transcription factor CSL (RBP-
Jk) (black rectangle) from a repressor to an ac-
tivator. Hence, all direct Notch effects through
this mechanism are positive. One direct effect
is shown at the top level of a regulatory cas-
cade, activating ‘‘Gene a,’’ which causes acti-
vation of downstream regulatory genes ‘‘b’’
and ‘‘c,’’ the proximal regulators of T cell genes
T1–T4. A second direct effect is combinatorial
participation in downstream gene activation,
here shown on target gene T1. A third pathway
for Notch action in T lineage specification is to
prevent expression of a T lineage antagonist
(Gene X). Notch signaling can exert lineage
protection by repression, though its effect
must be indirect, via inducing expression of an-
other factor (product of Gene b) that represses
the antagonist. Finally, as described for effects
onEBFandPU.1, Notch canact as apotentially
direct inhibitor ormodulator of the T lineage an-
tagonist protein itself (‘‘direct lineage protec-
tion’’), but in this case the mediator needed
for this effect remains to be determined (right
hand arrow from Notch, ‘‘unknown pathway’’).hematopoietic cells into the T cell program. This may
appear ironic, because Notch signaling plays extremely
diverse roles in development of all animal embryos (Bray,
2006; Artavanis-Tsakonis et al., 1999). Notch action be-
comes a T lineage driver only because of the specific
context provided by other transcription factors in hemato-
poietic precursors. Yet not only does Notch-Delta interac-
tion trigger initiation of the T cell program, but it also acts
repeatedly thereafter to sustain the cells throughout the
pro-Tcell stages (reviewedbyMaillard et al., 2005). Asa re-
sult, the whole early role of the thymic epithelial architec-
ture can be replaced in monolayer coculture systems for
T cell development simply by engineering OP9 or other
stromal cells to express the Delta-class Notch ligands
DL1 or DL4 (Besseyrias et al., 2007; Mohtashami and
Zu´n˜iga-Pflu¨cker, 2006; Schmitt and Zu´n˜iga-Pflu¨cker,
2002). Notch effects on precursors are exerted through
multiple mechanisms, because the other transcription
factors with which Notch must cooperate shift as the cells
progress through development (Figure 2).
In vivo, it is likely that most lineage-determining effects
of Notch occur in the thymic microenvironment, where
Notch initiates and drives progression of early T cell devel-
opment (see Bhandoola et al., 2007, this issue). Induction
of Notch target genes such asHes1 appears to await entry
into the thymus, at least in fetal systems (Harman et al.,
2003; Masuda et al., 2005b). Then, however, c-Kit+ DN1
cells rapidly come to require Notch signaling for their gen-
eration and maintenance (Krueger and von Boehmer,692 Immunity 26, June 2007 ª2007 Elsevier Inc.2007;Sambandamet al., 2005; Tan et al., 2005). Notch sig-
naling continues, as target genes Ptcra, Dtx1, and Notch1
and Notch3 themselves (Weng et al., 2006; Reizis and
Leder, 2002;Deftos et al., 2000) aremaximally upregulated
between DN2 and DN3 stages (Tydell et al., 2007; Taghon
et al., 2006; Balciunaite et al., 2005; Gounari et al., 2002;
Huang et al., 2003; Izon et al., 2002). DN3 thymocytes re-
main dependent on Notch signaling for survival (Ciofani
and Zu´n˜iga-Pflu¨cker, 2006), in part because Notch signal-
ingpositively regulatesc-Myc (Wengetal., 2006;Palomero
et al., 2006), and they require Notch-Delta signals for full
competence to undergo b-selection (Taghon et al., 2006;
Garbe et al., 2006; Ciofani et al., 2006). The cells become
independent of Notch signaling only through b selection
or gd selection, when commitment is essentially complete.
In vitro systems make it possible to dissect the mecha-
nisms through which Notch signals regulate choice of the
T cell lineage (Figure 2; Schmitt and Zu´n˜iga-Pflu¨cker,
2002). In prethymic hematopoietic precursors, Notch-
Delta interaction can trigger a transcriptional cascade
that initiates T lineage gene expression over a period of
3–6 days (Ho¨flinger et al., 2004; Tydell et al., 2007; Taghon
et al., 2005). Nonlineage-specific Notch targets such as
Hes1 are upregulated in the first day, and partially cell
type-specific target genes such as Dtx1 (Deltex1) are up-
regulated in the next day. Then, with seemingly exponen-
tial induction kinetics, the T cell regulatory genes Gata3,
Tcf7 (encoding TCF-1), and Bcl11b are induced in the
following days along with T lineage differentiation genes
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genes are direct Notch targets (Figure 2, e.g., gene T1),
others may be activated indirectly through a cascade
(Figure 2, genes T2 and T3): for example, once GATA-3,
TCF-1, and CD33 are expressed in fetal thymocytes,
they require little if any continuing Notch input to sustain
expression (Taghon et al., 2007; Franco et al., 2006).
These initial effects of Notch triggering are not sufficient
to cause lineage commitment, because they occur at time
points in vitro and at stages in vivo when the cells are still
uncommitted. As discussed below, however, Notch
signaling has yet another role to bias cellular choices
between the T lineage and each of the other alternative
fates that pro-T cells can adopt.
The Choice between T and B Lineage Fates
T and B lineage fates might appear closely linked. They
share the distinctive use of RAG-1- and RAG-2-depen-
dent recombination for assembling their receptor genes;
they both use antigen-driven cytokine receptor expres-
sion to link growth to immunological response; and they
both depend on bHLH E proteins, TCF family proteins,
and Ikaros family proteins for their developmental
programs. However, these two pathways actually diverge
relatively early, and they must separate, because of their
dichotomous responses toNotch-Delta signaling. Although
B lineage cells become resistant to inhibition by Notch
once their differentiation program is under way, entry
into the B cell pathway is exquisitely intolerant of Notch-
Delta signaling. Titration experiments with g-secretase in-
hibitors, which pharmacologically inhibit Notch activation,
show that B lineage development can be arrested even
under conditions of low Notch signaling, inadequate for
T cell development (Schmitt et al., 2004; Lehar et al.,
2005; De Smedt et al., 2005).
B cell differentiation depends on the activity of E2A
and two other transcription factors, EBF and Pax5, with
uniquely B lineage expression and well-defined roles in
the B cell-specification network and B cell gene expres-
sion (Hagman and Lukin, 2006; Busslinger, 2004; Singh
et al., 2005). EBF and Pax5 are not generally expressed
in stem cells, but need to be induced de novo in early
B cell differentiation (Yokota et al., 2003; Igarashi et al.,
2002). Importantly, no expression of these key B lineage
factors is detected in purified c-Kit+ DN1 or DN2 cells
(Balciunaite et al., 2005; M.A. Yui and E.V.R., unpublished
data). Thus, their induction is blocked or reversed in any
cells that enter the thymus.
EBF expression can be compatible with T cell potential
in uncommittedprecursors, provided thatPax5 remains si-
lent. For example, Pax5-deficient pro-B cells that express
abundant EBF can respond to Notch-Delta signaling: they
efficiently differentiate into T cells (Ho¨flinger et al., 2004;
Rolink et al., 1999), andEBF is shut off as theTcell program
gets under way. However, Pax5 expression in prethymic
cells is prohibitive. At least in part this is because Pax5 can
shut off expression of Notch1 at the RNA level (Souabni
et al., 2002). Thus, earlyPax5expressionmayprevent T lin-
eage initiation or undermine T lineage cell survival, or both,throughout the Notch-dependent stages. The permanent
silencing of EBF and Pax5 is likely to be critical for pro-T
cell development.
In prethymic multipotent precursors, Notch-Delta sig-
naling in vitro can block induction of both EBF and Pax5,
thus preventing or indefinitely deferring B lineage specifi-
cation (Figure 2, lineage protection via repression; Taghon
et al., 2005). Notch signaling apparently antagonizes EBF
activity at the protein level as well (Figure 2, direct lineage
protection; Smith et al., 2005). EBF and Pax5 may not
even be the only targets of Notch inhibition. In some cells,
Notch signaling can even trigger destabilization of E2A
(Nie et al., 2003) that B cells require, although this may not
promote the T lineage fate where E2A is needed as well. At
a minimum, the direct opposition of Pax5 and Notch in a
mutually repressive circuit makes the B cell option funda-
mentally incompatible with early T cell development and
forces an early exclusive lineage choice.
Strikingly, B cell development in vivo can occur only
from cells that are protected from Notch signaling. New
evidence shows that the BTB/POZ-Kru¨ppel family tran-
scriptional repressor, Zbtb7a (also known as LRF or Poke-
mon), is needed to play this role in hematopoietic precur-
sors (Maeda et al., 2007). This factor seems to be critical to
limit expression of Notch1, Notch3, and their target genes
to low levels in pre-pro-B cells, and it prevents spontane-
ous Notch pathway activation from driving T cell develop-
ment in the bone marrow. It does not appear to be used in
the B cell developmental program per se, because it
seems to be dispensable for B cell development as long
as Notch signaling is inhibited. Thus, a dedicated Notch
antagonist is a prerequisite for B lineage initiation before
Pax5 is ever induced.
High levels of Zbtb7a expression may explain how, in
fetal liver multipotent progenitor populations, at least
somecells canwithstandmultiple days of contactwithOP9-
DL1 stroma and yet retain ability to differentiate to the
B lineage, if switched to a permissive OP9-control culture
(Taghon et al., 2005). For these cells, contact with OP9-
DL1 has prevented induction of EBF and Pax5 but has not
yet silenced thempermanently. However, purified subsets
of intrathymic pro-T cells placed in the same OP9-control
cultures do not upregulate EBF (Taghon et al., 2007) or de-
velop into B cells, but give rise to NK cells or DCs instead
(Sambandam et al., 2005; Porritt et al., 2004). Thus, what
has happened to the thymocytes in vivo is something
more durable than a few days of Notch-Delta signaling:
key permissive conditions for activation of the B cell pro-
gram have been disabled in these intrathymic T lineage
precursors, in a way that is no longer dependent on
continuing Notch signals.
The silencing mechanism is not yet defined, but it may
not strictly be mediated by Notch at all. In the fetus, the
loss of B lineage potential occurs even before contact with
Notch ligands in the thymic microenvironment (Harman
et al., 2005; Masuda et al., 2005a, 2005b). In the adult as
well, a prethymic cell type has recently been described
that characteristically shows T but not B potential, and
this population can apparently be generated even fromImmunity 26, June 2007 ª2007 Elsevier Inc. 693
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activation is blocked (Krueger and von Boehmer, 2007).
Loss of Zbtb7a may contribute but does not seem to be
the sole cause of loss of B cell potential because c-Kit+
DN1 thymocytes (‘‘ETP’’) that have already lost B cell po-
tential (Allman et al., 2003) still express copy numbers of
Zbtb7a RNA molecules as high as in B lineage-biased
‘‘common lymphoid precursors’’ from bone marrow
(Maeda et al., 2007). Thus, it is likely that the EBF and
Pax5 genes are permanently silenced by some combina-
tion of Notch-dependent and other mechanisms in early
intrathymic pro-T cells.
A Foundation for Lineage Plasticity: Persistence
of Stem Cell Regulatory Components
In contrast to B cell potential, other developmental poten-
tials persist in Notch-signaled precursors as they begin
intrathymic development. In fact, pro-T cells express nu-
merous transcription factors associated with other line-
ages, implying that intrathymic pro-T cells maintain a large
part of the ‘‘multilineage priming’’ that is thought to be
characteristic of stemcells andmultilineagehematopoietic
precursors (Hu et al., 1997; Miyamoto et al., 2002). Two
groups of regulatory genes that play active roles in alterna-
tive programs are notable. One consists of factors that are
expressed in the DN1 stage, present though declining in
the DN2 stage, and finally shut off by the DN3 stage. The
other is a remarkably broad set of regulatory genes that
are expressed persistently, at quantitatively stable levels,
fromprethymic stemcell all theway through theDN3 stage
until b selection (Tydell et al., 2007). These overlapping in-
heritances from stem cells blur the distinction between
multilineage prethymic precursors and pro-T cells.
The first pattern, of ‘‘non-T lineage’’ factors spilling over
into the intrathymic stages, was first noted for PU.1 and
Id2, where an association with developmental potential
was immediately suggested. PU.1, known to be important
for myeloid development, is expressed in T cell precursors
only throughout the same stages of T cell development
when monocytic and DC potential is preserved (Anderson
et al., 1999, 2002; Spain et al., 1999). Id2, which is required
for NK cell development, is also expressed through the
pro-T stages when NK potential is retained (Ikawa et al.,
2001; Wang et al., 2006; David-Fung et al., 2006). These
expression patterns are not artifacts of contamination, be-
cause recent evidence shows that all the early intrathymic
T cell precursors appear to pass through a strongly PU.1-
expressing stage. Absolute amounts of PU.1 RNA expres-
sion in c-Kit+ DN1 populations are as high as in prethymic
multilineage precursors (Tydell et al., 2007), and a PU.1-
GFP knockin transgenic mouse shows high, homoge-
neous GFP expression throughout the c-Kit+ DN1 popula-
tion with label persisting in the DN2 population (Nutt et al.,
2005). PU.1 expression is essential for T lineage develop-
mental competence (Scott et al., 1994; Spain et al., 1999;
Dakic et al., 2005). Thus, PU.1 expression has provided
a first hint that a factor essential for the T lineage fatemight
also be playing a role in maintaining a non-T alternative
(see also Iwasaki and Akashi, 2007, in this issue).694 Immunity 26, June 2007 ª2007 Elsevier Inc.Other ‘‘lineage-inappropriate’’ genes with similar pro-
files to PU.1 and Id2 are those encoding the stem cell leu-
kemia (SCL, also called Tal-1) bHLH transcription factor,
and the Zn-finger repressor Bcl11a. Both are expressed
stably from stem cells and other multipotent prethymic
progenitors into the DN1 stage, declining thereafter (Tydell
et al., 2007). At lower amounts, the stem andmast cell reg-
ulator GATA-2 and the granulocyte regulator C/EBPa are
also detectable in a declining pattern in the DN1 and DN2
stages (Laiosa et al., 2006b; Tabrizifard et al., 2004; M.A.
Yui, E.-S. David-Fung, and E.V.R., unpublished results).
These changes occur against the background of the
much larger cohort of stem or progenitor cell regulatory
genes that continue to be expressed in pro-T cells through
the DN1–3 stages, until b selection (Tydell et al., 2007;
E.-S. David-Fung and E.V.R., unpublished data). These
genes not only encode MLL1, MLL2, and Myb, known to
have multilineage roles, but also encode regulators asso-
ciated with particular alternative lineages, like the ery-
throid and megakaryocytic regulators, FOG-1 and Nfe2,
and themast-cell and neural crest-cell regulator,Mitf (M.A.
Yui, E.-S. David-Fung, and E.V.R., unpublished data). The
amounts of these factors in pro-T cells are well above de-
tection threshold and can be strongly responsive to trans-
activation (Taghon et al., 2007). Thus, pro-T cells retain
elements of a permissive regulatory repertoire for multiple
non-T cell fates.
Expression of factors associated with other lineages is
not in itself enough to explain the persistence of develop-
mental plasticity. However, with respect to ‘‘myeloid’’ fates
at least, there is now increasing causal evidence to show
how these factorsmightwork tokeepalternativesavailable.
A Detour Left Open: The Dendritic
and Monocyte Options
The best-dissected component of the T lineage commit-
ment process is the regulation of access to the dendritic
and monocyte programs (see also Iwasaki and Akashi,
2007, and Wu and Liu, 2007, in this issue). These options
remain accessible to pro-T cells late enough so that the
mechanisms mediating competition among the potential
fates can be studied in a highly defined developmental
context. Monocyte, DC, and neutrophil developmental
fates are governed primarily by transcription factors of two
families: PU.1 (also called Spi-1) or its relative Spi-B and
C/EBPa or its relative C/EBPb (Laiosa et al., 2006a; Dontje
et al., 2006; Koschmieder et al., 2005; Dahl et al., 2003;
Schotte et al., 2003; Friedman, 2002). These factors partic-
ipate inmost if not allmyeloid-specific geneexpression that
has been studied to date. High ratios of PU.1 to C/EBPa
favor monocyte development, whereas low ratios favor
neutrophil development (Dahl et al., 2003). It now appears
that these ratio-based subdecisions are executed by sec-
ondary regulatory circuits in which PU.1-induced Egr family
zinc finger factors oppose Gfi-1 (Laslo et al., 2006). Distinct
subsets of DCs are programmed by combinations of PU.1
or Spi-Bwith E proteins (Spits et al., 2000), on the one hand,
or with Id2 and Smad factors, on the other hand (Hacker
et al., 2003). However, for all of these outcomes, Spi or
Immunity
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rate-limiting. In thymocytes, access to monocytic and den-
dritic programs appears to be fully explained in terms of the
expression or inducibility of these factors.
PU.1 expression in thymocytes is highly correlated with
‘‘myeloid’’ potential as already described. Thymocytes
from PU.1-deficient mice cannot generate DCs in vitro
(Lefebvre et al., 2005). Importantly, in later-stage thymo-
cytes that have shut off their own PU.1 expression, trans-
duction of PU.1 restores the ability to develop into mono-
cytic cells and DCs, reversing T lineage commitment
(Laiosa et al., 2006b; Franco et al., 2006; Dionne et al.,
2005; Lefebvre et al., 2005). Thus, PU.1, as long as it is ex-
pressed, has the power as well as the natural opportunity
to be responsible for preserving these ‘‘myeloid’’ fate op-
tions for pro-T cells.
Another potential contributor to myeloid or DC potential
is the PU.1 relative, Spi-B, which is expressed in pro-T
cells only until b selection or gd selection and then shut
off permanently (Anderson et al., 1999; Lefebvre et al.,
2005; Taghon et al., 2006). This factor is clearly implicated
in DC development from human thymocytes, and it can
also actively promote murine thymocyte conversion to
DCs when overexpressed (Dontje et al., 2006; Schotte
et al., 2004; Lefebvre et al., 2005). It is a little murky how
Spi-B expression contributes to murine thymocyte plas-
ticity in vivo, because its expression pattern peaks at the
DN3 stage, just when DC potential is thought to disappear
(David-Fung et al., 2006; Lefebvre et al., 2005; Anderson
et al., 1999). Nevertheless, Spi-B activity may explain
some contexts in which DCs are seen in vivo in PU.1
mutant mice (Guerriero et al., 2000).
When forcibly expressed in DN2, DN3, or even later T
lineage precursors, PU.1 begins by dismantling the T line-
age identity of the cells, even before the cells show signs
of acquiring a new identity. Within the first day (Franco
et al., 2006), PU.1 sharply downregulates multiple T line-
age transcription factors as well as TCR-signaling compo-
nents and other differentiation genes. These repressive
events accompany the first detectable positive regulatory
changes, as PU.1 upregulates CD11b transcription, and
precede the appearance of substantial Mac-1 at the cell
surface. Within 2 days, the cells upregulate Id2, Egr2,
and M-CSF-R and repress Gfi-1, making a coordinated
approach toward the requirements for differentiation and
survival as a monocyte (Laslo et al., 2006). Upregulation
of Id2 is a central feature of diversion by both PU.1 and
C/EBPa (Laiosa et al., 2006b; Franco et al., 2006; Fukuchi
et al., 2006), and PU.1 exacerbates the effects by down-
regulating E proteins simultaneously, a potentially central
element of a bistable T versus myeloid lineage switch (see
Rothenberg,2007). By 3 or 4 days after transduction, PU.1-
transfected thymocytes also upregulate C/EBPa (Franco
et al., 2006), and this may consummate the lineage switch.
Direct transfection of C/EBPa or b is also sufficient to
drive remarkably efficient myeloid conversion of thymo-
cytes from a postcommitment stage, long after endoge-
nous C/EBPa and b appear to be shut off (Laiosa et al.,
2006b). Although the levels of C/EBP factors reached inthese transfectants are not known, they can turn on mye-
loid differentiation genes detectably within 2 days and fully
differentiate postcommitment thymocytes to inflamma-
tory macrophages within 9 days. Transfected C/EBP fac-
tors are ultimately capable of reactivating PU.1 expression
in DN3 or later stage cells, although this is not an immedi-
ate effect, and can also activate a subset of myeloid genes
even when PU.1 is genetically deleted (Laiosa et al.,
2006b). Activation of C/EBPa from a tamoxifen-activated
transgene in vivo also blocks T cell development severely
from the DN1 and DN2 stages, possibly via downregula-
tion of Notch and upregulation of E protein antagonists
Id2 and Id3 (Fukuchi et al., 2006).
It is not clear how closely transduced C/EBP activity
matches DN1 pro-T cell expression. In vivo, c-Kit+ DN1
and DN2 cells normally maintain much lower apparent ex-
pression of C/EBPa and C/EBPb than of PU.1, perhaps
explaining the relative inability of these cells to generate
neutrophils normally. However, these naturally PU.1-
expressing pro-T cells can efficiently upregulate C/EBP
if they are artificially triggered by stimulation of an ectopic
cytokine receptor, such as a transgene encoding IL-2Rb
(CD122) or GM-CSF-Ra (Csf2r) (Iwasaki-Arai et al., 2003;
Hsu et al., 2006). In such cases, cytokine stimulation of
transgenic DN1 and DN2 cells through an ectopically ex-
pressed IL-2Rb or GM-CSF-R can induce myeloid lineage
conversion even without exogenous C/EBP or PU.1 (Iwa-
saki-Arai et al., 2003; King et al., 2002) (importantly, stim-
ulation of the IL-7R that drives most pro-T cell expansion
does not appear to do this). Thus, physiological limitations
on C/EBP factor inducibility in pro-T cells are likely to be
critical for T lineage fidelity.
Conditionality of Pathways for Dendritic
and Monocytic Lineage Diversion:
Restraint before Commitment
One reason that PU.1 and C/EBPa do not turn all c-Kit+
DN1 cells into myeloid cells is, of course, dose. The ex-
pression amounts achieved in transduction experiments
are generally higher than endogenous amounts in DN1
cells, where they have beenmeasured (Franco et al., 2006;
Anderson et al., 2002). In vivo, though, there is another
check on diversion: environmental Notch-Delta signaling
exerts a natural restraint on the activities of these factors.
This natural intrathymic restraint mechanism not only rec-
onciles the potency of PU.1 and C/EBP factors in lineage-
diversion experiments with their innocuousness in the
context of the normal thymus, but also provides support
for their biological relevance in maintaining alternative
latent developmental potentials for pro-T cells in vivo
(Garcia-Peydro et al., 2006).
The existence of threshold-setting mechanisms for
these diversionary effects was first suggested by experi-
ments in which forced expression of PU.1 was used to re-
program subclones from the DN3-like immortal cell line,
SCID.adh (Dionne et al., 2005). The cell-line studies re-
vealed a discontinuous, all-or-none switch-like response
to PU.1 with dichotomous outcomes even within clones
freshly derived from single cells (Dionne et al., 2005),Immunity 26, June 2007 ª2007 Elsevier Inc. 695
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nist that sets thresholds for diversion. More recently, in
freshly isolated DN2 andDN3 pro-T cells, Notch-Delta sig-
naling has been shown to provide such an antagonist.
PU.1-overexpressing cells are not diverted if they receive
continuing Notch-Delta interaction (Laiosa et al., 2006b;
Franco et al., 2006); instead, they can recover and develop
all the way to the DP stage under these conditions, pro-
vided that some general viability support is present (e.g.,
a Bcl2 transgene). The response to PU.1 does not appear
to be based on the kind of direct mutual repression of
Notch that is seenwithC/EBPaorwith theBcell regulators
EBF and Pax5. Notch signaling does not directly repress
PU.1, and even when PU.1 is forcibly overexpressed in
DN2 and DN3 thymocytes, there is no inhibition of Notch
expression or Notch signaling as measured by Ptcra or
Dtx1 target gene expression (Franco et al., 2006). Thus,
Notch signals canmodulate the response toPU.1 through-
out at least the first 2 days, and they do so by protecting
most susceptible T lineage genes from downregulation
by high PU.1, either partially or completely. Especially dra-
matic protective effects are seen on Myb, Gfi1, and net E
protein expression (Franco et al., 2006).
Remarkably, Notch signaling can also prevent lineage
diversion by forced expression of C/EBPa (Laiosa et al.,
2006b). This is noteworthy for two reasons. First, one
pathway for Notch effects appeared to be to inhibit
C/EBPa induction (Taghon et al., 2007; Franco et al.,
2006), and forced expression of C/EBPa ought to bypass
this restraint. Second, C/EBPa-transduced thymocytes,
unlike PU.1-transduced thymocytes, appear to shut off
expression of Notch within 2 days (Laiosa et al., 2006b).
Thus, Notch signaling must quickly interpose a block to
respecification at yet a different level.
One gene induced, directly or indirectly, by Notch sig-
naling during T lineage initiation is Gata3. The activity of
both Spi and C/EBP family factors can be inhibited at
the protein level by forced expression of GATA family tran-
scription factors in particular cellular contexts (Nerlov
et al., 2000; Rekhtman et al., 1999; Zhang et al., 1999;
Tong et al., 2005). Forced high coexpression of GATA-3
with C/EBPa or Spi-B can prevent thymocytes from ac-
quiring a myeloid or dendritic phenotype (Laiosa et al.,
2006b; Dontje et al., 2006), raising the possibility that
GATA-3 mediates Notch protective activity. However, in
pro-T cells normally, GATA-3 amounts are unlikely to be
high enough to antagonize PU.1 (David-Fung et al., 2006;
Tydell et al., 2007), and at moderate amounts, PU.1 and
GATA factors cooperate rather than antagonizing (Walsh
et al., 2002). Importantly, in PU.1-transduced thymocytes,
there is little effect on GATA-3 RNA amounts whether
Notch signaling is present or not (Franco et al., 2006).
Furthermore, as described below, forcing expression of
GATA-3 in large excess over PU.1 does not promote T lin-
eage differentiation, but rather a different form of lineage
diversion. This makes GATA-3 unlikely to account fully
for the protection of T lineage identity.
The ability of Notch to dominate PU.1 activity is only
seen in cells that have successfully initiated the T cell pro-696 Immunity 26, June 2007 ª2007 Elsevier Inc.gram, i.e., DN2 or later cells. The exception is in DN1-like
fetal thymocytes, the one state where Notch expression it-
self canbe inhibited byexcessive amounts of PU.1 (Franco
et al., 2006), and the negotiation between cell fates is likely
to be more dynamic. An attractive possibility is that the T
cell program induced at the DN2 stage may include ex-
pression of specific repressors that block the imposition
of alternative fates, and that these are among the T lineage
transcription factors thatNotchprotects fromdownregula-
tion, e.g., Bcl11bor a complexwithGfi-1. Such repressors,
once maintained or restored by Notch signaling, may then
prevent the shift to a new identity by specifically antagoniz-
ing the activities of PU.1 and C/EBPa or of any collabora-
tors, such as Egr2 and Id2, that would be needed to pro-
mote the monocyte or DC options. Of course, another
overlapping or distinct set of repressors in vivo eventually
silences expression of C/EBPa and PU.1 themselves,
and our discussion implies that this is a major component
of the T lineage commitment mechanism.
Notch Signaling as a General T Lineage Enforcer
Before commitment, Notch can protect T cell lineage pre-
cursors from diversion in at least two additional situations.
One is the NK cell alternative, and the other is a newly de-
scribed lineage alternative, both available to c-Kit+ DN1
and DN2 pro-T cells. Notch signaling does not shut off
either one of these options permanently but suppresses
access until the cells graduate to the committed DN3
stage (Taghon et al., 2007; Carotta et al., 2006; Rolink
et al., 2006; Schmitt et al., 2004).
The NK cell fate appears to be open to thymocytes as
long as they express substantial amounts of endogenous
Id2 (Ikawa et al., 2001), the antagonist of the bHLH E pro-
teins E2A and HEB. There is particularly strong evidence
for NK cell development from fetal thymocytes, which turn
out to express substantially higher amounts of Id2 RNA
than corresponding stages of postnatal thymocytes
(David-Fung et al., 2006). Forced expression of Id2 or its
relative, Id3, can redirect pro-T cells to NK cell differentia-
tion (Blom et al., 1999; Spits et al., 1998). NK cell develop-
ment also depends on many additional transcription fac-
tors, but as a rule these are also expressed in T lineage
cells (Di Santo, 2006; Glimcher et al., 2004; Lian and Ku-
mar, 2002). Like myeloid potential, NK cell potential in mu-
rine pro-T cells is limited by Notch-Delta signaling (Garcia-
Peydro et al., 2006; De Smedt et al., 2005; van den Brandt
et al., 2004; Schmitt et al., 2004). Conceivably, Notch
could block both options through limiting expression of
Id2, but this remains to be tested. Although both DN1
and DN2 cells can generate NK cells in the absence of
Notch signals, only DN1 cells can generate NK cells when
Notch signaling is present (Schmitt et al., 2004). Thus,
there is a striking increase in Notch potency at the DN2
stage, reminiscent of the increased effectiveness of Notch
to protect against PU.1-driven diversion at this stage.
Very recent evidence shows that the T lineage-
‘‘specific’’ transcription factor GATA-3 is intrinsically
dose dependent in its effects on early T cell development;
even GATA-3 is capable of acting as a diversionary factor
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ghon et al., 2007). This response is available to DN1 and
DN2 pro-T cells but not to DN3 cells, and it provides yet
another system in which Notch-Delta signaling restrains
the alternative fate. In DN1 and DN2 cells, highly abundant
GATA-3 induces a distinct differentiation response and
a different spectrum of gene-regulatory changes than
PU.1 or C/EBP factors, whereas it represses a far nar-
rower set of T lineage genes than PU.1. Notch signaling
here conspicuously blunts numerous positive regulatory
effects of GATA-3, both in the immediate response to
GATA-3 elevation and in the later stages of the alternative
differentiation cascade (Taghon et al., 2007). Because
GATA-3 continues to be expressed and essential through
T cell development (Hendriks et al., 1999; Pai et al., 2003),
unlike PU.1, access to this fate cannot be controlled by
shutoff of GATA-3; it must involve at least one additional
regulatory ‘‘input’’ that is not yet defined. By the DN3
stage, the additional condition required for diversion in re-
sponse to GATA-3 is blocked or removed, and GATA-3 is
‘‘tamed’’ for exclusively T lineage effects.
These examples show that through diverse mecha-
nisms, the regulatory input from Notch-Delta signaling is
interpreted in multiple regulatory contexts as a ‘‘course
correction’’ mechanism to prevent deviations from the T
lineage program. These effects are strongest in cells that
have already initiated T cell development and have pro-
gressed to the DN2 stage, and they buffer the develop-
mental identity of the cells until the more profound regula-
tory changes that occur with commitment.
Commitment Machinery: An Open Frontier
Through the DN2 stage, the developmental plasticity of
thymocytes can be attributed to the continuing expression
of transcription factors that are capable of promoting al-
ternative fates. An important reason the cells remain in
the T cell pathway in spite of these alternative potentials
is the continuing monitory influence of Notch-Delta signal-
ing. The requirement for this activity of Notch is even
stronger because most if not all of the endogenous tran-
scription factors that are required for T lineage differentia-
tion have the ability to promote non-T cell fate decisions as
well (Rothenberg, 2007). Even GATA-3 has this diversion-
ary potential (Taghon et al., 2007), although it is initially in-
duced by Notch signaling, expressed selectively in T cells,
and used repeatedly through T cell development. T line-
age identity is not ‘‘instructed;’’ it is ‘‘negotiated’’ among
these factors. Thus, in addition to the known effects of
Notch signaling to initiate T cell development and to pre-
serve pro-T cell viability, there is a need for Notch signal-
ing to weigh in on the T cell side of the balance among
developmental fates.
This unstable condition cannot persist, and at the DN3
stage the NK, DC, and other developmental potentials
cease to be accessible. This is likely to reflect a major de-
velopmental regulatory change rather than a temporary in-
terruption in plasticity (e.g., by cell-cycle arrest), because
later T cell development becomes independent of Notch-
dependent transcription immediately after b selection (Ta-nigaki et al., 2004). The circumstantial evidence reviewed
above indicates that the commitment process is based at
least in part on specific negative regulatory events. These
clearly include the full repression of PU.1 and Id2 and pos-
sibly involve imposition of long-term silencing on genes
encoding C/EBPa, SCL (Tal-1), and GATA-2 as well as
PU.1. An important question, still unanswered, is how
these major changes come about.
There are both DN3-specific transient regulatory
changes and long-term regulatory changes that initiate
at the DN3 stage. The DN3 stage, before b or gd selection,
marks a peak of expression of a number of transcriptional
regulators, including Spi-B, Runx1, and multiple Notch
pathway components (David-Fung et al., 2006; Taghon
et al., 2006; Huang et al., 2003; Izon et al., 2002). Some,
like Spi-B, are never expressed in thymocytes again.
There may be a distinct burst of Notch pathway activation
at the DN3 stage, as noted above, and several of the
Notch target genes peaking at this stage encode
transcriptional repressors. However, thus far none of
these transiently expressed factors have been causally
connected to the repression of PU.1 and Id2 and the
imposition of commitment. For example, PU.1 does not
appear to be repressed by Notch signaling as such: in
the short term, PU.1 expression is sustained or even
slightly enhanced in thymocytes in response to Notch-
Delta signaling in vitro (Taghon et al., 2007; Franco et al.,
2006).
Several potentially interesting transcription factors are
strongly upregulated at DN3 stage and then sustained in
later T cell development. These include the TCF family
member LEF-1, Ets2, and Pou6f1 (David-Fung et al.,
2006), though little is known yet to indicate specific re-
pressive roles for these factors. Perhaps a better candi-
date is SATB1, which is known to mediate large-scale
chromatin conformation changes needed for accurate re-
pression and is vital for normal T cell development (Cai
et al., 2003). An interesting new candidate to consider
for a commitment-linked repression activity is Bcl11b,
a transcriptional repressor (Avram et al., 2002) that is dra-
matically upregulated starting at the DN2 stage (Tydell
et al., 2007) and has some crucial but unexplained role
in generating DN3 cells that are competent to undergo b
selection (Kamimura et al., 2007; Inoue et al., 2006; Oka-
zuka et al., 2005). These and other factors require further
investigation.
Conclusions
The plasticity that pro-T cells maintain throughout most if
not all of their TCR-independent expansion appears to be
based on two elements. One is the delay in fully silencing
stem and progenitor-associated regulatory genes like
PU.1. The other is the intrinsic lineage promiscuity of the
essential T lineage regulatory factors themselves, at least
those studied to date (Rothenberg, 2007). The T lineage
program thus appears to be the emergent product of a net-
work, not simply of an instructive pathway, because bal-
ances between factors dynamically negotiate its proces-
sion of states.Immunity 26, June 2007 ª2007 Elsevier Inc. 697
Immunity
ReviewsFigure 3. Comparison of Gene-
Regulatory Network Architectures for B
and T Cell Specification
Components of B cell and T cell specification
networks as described in the text. The B line-
age pathway not only uses factors that have
B lineage-specific positive effects, but also ac-
tivates an intrinsic lineage fidelity factor, Pax5,
to repress non-B genes. The T lineage cas-
cade, initiated by Notch-Delta signaling, also
activates expression of several T lineage-asso-
ciated regulatory factors. However, to date,
none of these are known to have lineage-spe-
cific effects when overexpressed. Thus,
throughout the DN2 stage and possibly later
(depicted in middle right), continuing Notch-
Delta signaling is needed not only in a support-
ive role to sustain viability, but also in an active
modulatory role to suppress non-T effects of T
lineage-regulatory genes. Commitment (lower
right) is enforced by the repression and final si-
lencing of genes such as PU.1 that could drive
or support non-T lineage alternatives. Activities
of factors like GATA-3 are thus channeled to T
lineage-specific roles such as the support of
b selection.From this view, the T cell-specification process is rather
different in regulatory structure than B cell specification
(Figure 3, left). The B cell program is based on a trio of tran-
scription factors operating in a classic feed-forward regu-
latory cascade, and two of them, EBF and Pax5, are B lin-
eage specific within the hematopoietic context (Singh
et al., 2005). Not only are E2A, EBF, and Pax5 direct
drivers of most B lineage genes, but also Pax5 itself is
a major enforcer of B lineage fidelity through its direct an-
tagonism of other programs (Busslinger, 2004). This gives
developing B cells an intrinsic, cell-autonomous commit-
ment mechanism from a relatively early stage. In contrast,
the T cell program (Figure 3, right) is based on the mobili-
zation of combinations of factors that may not individually
be specific for regulation of T cell genes. Notch-Delta sig-
nalingmay thus be crucial throughout the extended period
of TCR-independent expansion to buffer pro-T cells
against fluctuations in the activity of their ‘‘own’’ factors,
to maintain a bias in favor of the T lineage outcomes. In
this way, the T cell lineage choice remains provisional,
highly dependent on extrinsic factors in the microenviron-
ment, through many rounds of cell division leading up to
TCR gene rearrangement.
This means that T cell development also requires a
mechanistically separate regulatory change, long after T
lineage gene expression is under way, to make T lineage698 Immunity 26, June 2007 ª2007 Elsevier Inc.commitment irreversible and to wean the cells from their
dependence on the thymic environment (Figure 3, bottom
right). For long-lived cells with enormous proliferative po-
tential like T cells, a trivial mechanism for commitment, like
mitotic arrest, will not do. The details of this commitment
mechanism, and its relationship to the choice of fates
between ab, gd, and perhaps other lineages of T cells,
are great questions for future discoveries to resolve.
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